Martin P. Sutter's most recent trade in Bioventus Inc - Ordinary Shares - Class A was a trade of 32,282 Restricted Stock Units done . Disclosure was reported to the exchange on June 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2026 | 32,282 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2026 | 32,282 | 117,523 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 25,146 | 25,146 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 32,282 | 32,282 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 85,241 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 58,748 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 28,348 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 11,700 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 9,000 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Martin P. Sutter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 0 | - | - | Restricted Stock Units |